LogiPharma USA 2025: Challenges Currently Impacting the Temperature-Controlled Space

In a recent panel discussion on supply chain security, Krenar Komoni, founder and CEO of Tive, emphasized the growing importance of collaboration among vendors, logistics providers, and technology companies to combat evolving threats in the industry. The conversation highlighted two main types of theft impacting the supply chain: direct theft, where goods are physically stolen from trailers or containers, and strategic theft, a more sophisticated form involving social engineering tactics where fake carriers impersonate legitimate ones to intercept shipments.

To address these risks, panelists discussed a multi-layered security approach. Tools like carrier vetting software, GPS trackers, seals, and even armed escorts were identified as part of a tiered defense system. Komoni stressed that no single solution can fully secure a supply chain; rather, companies must integrate multiple protective measures into their operations to build resilience.

A major highlight of the discussion was the shift in the pharmaceutical industry from passive monitoring to real-time tracking, accelerated by new technologies like the Solo Pro device. This transition enhances visibility and responsiveness in managing high-value or sensitive shipments.The panel also explored how closer partnerships between logistics providers, shippers, and tech firms are strengthening the supply chain. This “triangle” of collaboration allows for better implementation and use of advanced technologies, increasing trust and efficiency across the board.

Looking ahead, Komoni noted that AI and automation will play a larger role in supply chain security, helping to predict threats and streamline operations in a rapidly evolving environment. The session concluded with a clear takeaway: securing the supply chain requires continuous adaptation, strong relationships, and layered, technology-driven solutions.

A transcript of Komoni’s conversation with PC can be found below.

PC: What challenges are currently impacting the temperature-controlled space?

Komoni: So the temperature control space and all the various companies, especially in the pharmaceutical side, they're going through a transition phase, which I call it, going from passive to real time. And it's taking its time. And I wish we were there sooner, but there's a lot of reasons why we're not there yet. Technology providers haven't moved as fast we're finally just for instance, with dive, we released a solo pro device, which is a pharma specific real time tracker that meets all the 21 CFR Part 11 requirements. It's GXP compliant. And to be able to move everything from passive to real time, it's gonna take a little bit longer time. Call it another 12 months, maybe 24 to 36 months max. But this is one of the challenges right now, is this transition, and what comes with this transition as everything becomes more real time. Now, various workflow automations that need to be in place suddenly can actually work. And with AI and these workflow automations, customers are going to be able to get benefit from the real time data and see their costs go down, their quality go up, and customer experience improve.